P731 closed today higher at 3.06, an increase of 1.3245% from yesterday's close, completing a monthly increase of 0% or 0. Over the past 12 months, P731 stock gained 75.8621%.
P731 is not paying dividends to its shareholders.
The last earnings report, released on Feb 05, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0233%, based on the last three reports.
Medexus Pharmaceuticals Inc. has completed 1 stock splits, with the recent split occurring on Dec 19, 2018.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on TSX (CAD).